Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.15 (-7.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Short term Debt (2024 - 2025)

Updated

Jyong Biotech (MENS) recorded Short term Debt of $571,000 in the quarter ended Dec 31, 2025, up 901.8% from $57,000 a year earlier.

Analysis

Jyong Biotech (MENS) Short term Debt (2024 - 2025) Analysis & Trends

  • Across earlier years, Short term Debt came in at $57,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Jyong Biotech 121.38 Mn 121.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 571,000.00
Jun 30, 2025 349,000.00
Dec 31, 2024 57,000.00
API Access

Jyong Biotech Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=MENS&period=max&api_key=YOUR_API_KEY